< Back | |
24 Feb 2016 | |
Bal Pharma Ltd has informed BSE that ICRA has revised its long term credit rating of Bal Pharma Ltd to BBB (Pronounced as triple B) from BBB- (pronounced triple B minus) assigned by ICRA for the previous financial year.<BR><BR>ICRA also have revised the short term credit rating of Bal Pharma Ltd to A3+ (Pronounced A three plus) from A 3 ( pronounced as A three) assigned for last financial year 2014.15.<BR><BR>The up gradation of crediting rating of the Company is the indication of its significant improvement in the financial profile by expanding its margins and improvised cash flows. | |
View all announcements for BAL PHARMA LTD. | Source: BSE India |